These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17205648)

  • 1. Co-infections. Can hepatitis C virus help keep cholesterol levels low?
    TreatmentUpdate; 2006; 18(5):4-5. PubMed ID: 17205648
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N; Hiransuthikul P; Kanasook Y
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C management in HIV infection--where is the controversy?
    Dieterich DT
    AIDS Read; 2002 Jan; 12(1):22-3. PubMed ID: 11862657
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic abnormalities are associated with HIV and treatment.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(1):6-7. PubMed ID: 11810889
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-HCV Co-infection therapeutic outcomes have not improved over time.
    Cooper C; Costiniuk C; Giguère P
    HIV Clin Trials; 2009; 10(3):203-6. PubMed ID: 19632960
    [No Abstract]   [Full Text] [Related]  

  • 7. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
    AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/hepatitis co-infection.
    Rockstroh J
    J HIV Ther; 2007 Mar; 12(1):1. PubMed ID: 17589388
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvements in protease inhibitor-based HAART.
    Boyle BA
    AIDS Read; 2005 Dec; 15(12):659-60, 662. PubMed ID: 16355596
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of iron metabolism associated with protease inhibitor therapy.
    McNabb JC; Cappa JA; Ross JW
    Clin Infect Dis; 2001 Aug; 33(3):413-4. PubMed ID: 11438916
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical outcome after coronary events in patients treated with HIV-protease inhibitors.
    Monsuez JJ; Gallet B; Escaut L; Vayre F; Charniot JC; Pulik M; Merad M; Minozzi C; Slama M; Weber S; Vittecoq D
    Eur Heart J; 2000 Dec; 21(24):2079-80. PubMed ID: 11102259
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
    Brady CW; Muir AJ
    Hepatology; 2005 Aug; 42(2):496-7; author reply 497. PubMed ID: 16025502
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project.
    De Socio GV; Bonfanti P; Ricci E; Orofino G; Madeddu G; Penco G; Gianelli E; Martinelli C; Carradori S; Quirino T; Rizzardini G;
    Biomed Pharmacother; 2008 Jan; 62(1):16-20. PubMed ID: 17851026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of HAART in co-infected patients.
    AIDS Patient Care STDS; 2003 Nov; 17(11):603-4. PubMed ID: 14748356
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-infections. Some good news about HAART and liver health.
    TreatmentUpdate; 2008; 20(4):8. PubMed ID: 19248274
    [No Abstract]   [Full Text] [Related]  

  • 18. Nelfinavir safe and effective in HIV/HCV patients.
    AIDS Patient Care STDS; 2003 Nov; 17(11):602-3. PubMed ID: 14750219
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver toxicities rising.
    Pieribone D
    Posit Living; 2000 Aug; 9(7):19, 23. PubMed ID: 12492029
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus and metabolic disturbances.
    Nuñez M
    IAPAC Mon; 2005 Jul; 11(7):216-7. PubMed ID: 16676426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.